Bafna Pharmaceuticals Ltd banner

Bafna Pharmaceuticals Ltd
NSE:BAFNAPH

Watchlist Manager
Bafna Pharmaceuticals Ltd Logo
Bafna Pharmaceuticals Ltd
NSE:BAFNAPH
Watchlist
Price: 109.18 INR 2.04% Market Closed
Market Cap: ₹2.6B

Cash Flow Statement

Cash Flow Statement
Bafna Pharmaceuticals Ltd

Rotate your device to view
Cash Flow Statement
Currency: INR
Sep-2020 Mar-2021 Sep-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023 Mar-2024 Sep-2024 Mar-2025 Sep-2025
Operating Cash Flow
Net Income
47
58
119
73
19
118
177
73
3
42
88
Depreciation & Amortization
35
45
54
55
50
53
54
50
56
49
47
Other Non-Cash Items
(231)
(7)
(25)
(35)
(24)
16
33
30
34
52
56
Cash Taxes Paid
0
0
0
0
0
1
2
2
1
(4)
(4)
Cash Interest Paid
(0)
1
3
8
13
17
19
23
27
27
32
Change in Working Capital
(239)
(233)
(120)
(13)
(58)
(138)
(109)
(59)
50
79
(36)
Cash from Operating Activities
(389)
N/A
(136)
+65%
28
N/A
80
+187%
(14)
N/A
50
N/A
155
+213%
95
-39%
143
+50%
221
+55%
154
-30%
Investing Cash Flow
Capital Expenditures
(30)
(61)
(66)
(75)
(117)
(82)
(57)
(158)
(212)
(219)
(290)
Other Items
335
8
7
21
36
7
(10)
8
8
7
21
Cash from Investing Activities
305
N/A
(54)
N/A
(59)
-10%
(54)
+8%
(81)
-49%
(75)
+8%
(67)
+10%
(151)
-124%
(204)
-36%
(212)
-4%
(269)
-27%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
0
0
0
0
0
0
0
Net Issuance of Debt
(435)
124
19
(44)
136
119
(26)
15
22
38
136
Other
(47)
(1)
7
2
(13)
(17)
(19)
(23)
(27)
(27)
(32)
Cash from Financing Activities
72
N/A
123
+72%
26
-79%
(42)
N/A
123
N/A
102
-17%
(45)
N/A
(8)
+81%
(4)
+51%
11
N/A
104
+875%
Change in Cash
Net Change in Cash
(13)
N/A
(67)
-434%
(5)
+93%
(16)
-226%
28
N/A
76
+171%
43
-43%
(64)
N/A
(65)
-2%
20
N/A
(11)
N/A
Free Cash Flow
Free Cash Flow
(419)
N/A
(197)
+53%
(38)
+81%
5
N/A
(130)
N/A
(33)
+75%
98
N/A
(64)
N/A
(70)
-10%
3
N/A
(136)
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett